[1] |
Willemze R, Jaffe ES, Burg G, et al. WHO⁃EORTC classification for cutaneous lymphomas[J]. Blood, 2005,105(10):3768⁃3785. doi: 10.1182/blood⁃2004⁃09⁃3502.
|
[2] |
Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. 4th ed. Lyon: IARC Press, 2008.
|
[3] |
Elder DE, Massi D, Scolyer RA, et al. WHO classification of skin tumours[M]. 4th ed. Lyon: IARC Press, 2018.
|
[4] |
Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO⁃EORTC classification for primary cutaneous lymphomas[J]. Blood, 2019,133(16):1703⁃1714. doi: 10.1182/blood⁃2018⁃11⁃881268.
|
[5] |
Wilcox RA. Cutaneous B⁃cell lymphomas: 2016 update on diagnosis, risk⁃stratification, and management[J]. Am J Hematol, 2016,91(10):1052⁃1055. doi: 10.1002/ajh.24462.
|
[6] |
van Santen S, Roach RE, van Doorn R, et al. Clinical staging and prognostic factors in folliculotropic mycosis fungoides[J]. JAMA Dermatol, 2016,152(9):992⁃1000. doi: 10.1001/jamadermatol. 2016.1597.
|
[7] |
Plaza JA, Feldman AL, Magro C. Cutaneous CD30⁃positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases[J]. J Cutan Pathol, 2013,40(2):236⁃247. doi: 10.1111/cup.12047.
|
[8] |
McQuitty E, Curry JL, Tetzlaff MT, et al. The differential diagnosis of CD8⁃positive ("type D") lymphomatoid papulosis[J]. J Cutan Pathol, 2014,41(2):88⁃100. doi: 10.1111/cup.12243.
|
[9] |
Kempf W, Kazakov DV, Palmedo G, et al. Pityriasis lichenoides et varioliformis acuta with numerous CD30+ cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases[J]. Am J Surg Pathol, 2012,36(7):1021⁃1029. doi: 10.1097/PAS.0b013e31824f4f66.
|
[10] |
Marschalkó M, Gyöngyösi N, Noll J, et al. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis[J]. J Cutan Pathol, 2016,43(11):963⁃973. doi: 10. 1111/cup.12779.
|
[11] |
Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis[J]. Am J Surg Pathol, 2013,37(8):1173⁃1181. doi: 10.1097/PAS. 0b013e318282d01e.
|
[12] |
Onaindia A, Montes⁃Moreno S, Rodríguez⁃Pinilla SM, et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features[J]. Histopathology, 2015,66(6):846⁃855. doi: 10.1111/his.12529.
|
[13] |
Petrella T, Maubec E, Cornillet⁃Lefebvre P, et al. Indolent CD8⁃positive lymphoid proliferation of the ear: a distinct primary cutaneous T⁃cell lymphoma?[J]. Am J Surg Pathol, 2007,31(12):1887⁃1892. doi: 10.1097/PAS.0b013e318068b527.
|
[14] |
Kluk J, Kai A, Koch D, et al. Indolent CD8⁃positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient[J]. J Cutan Pathol, 2016,43(2):125⁃136. doi: 10.1111/cup.12633.
|
[15] |
Cetinözman F, Jansen PM, Willemze R. Expression of programmed death⁃1 in primary cutaneous CD4⁃positive small/medium⁃sized pleomorphic T⁃cell lymphoma, cutaneous pseudo⁃T⁃cell lymphoma, and other types of cutaneous T⁃cell lymphoma[J]. Am J Surg Pathol, 2012,36(1):109⁃116. doi: 10.1097/PAS.0b013e318230df87.
|
[16] |
Balagué O, Martínez A, Colomo L, et al. Epstein⁃Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T⁃cell lymphomas: a phenomenon with distinctive clinicopathologic features[J]. Am J Surg Pathol, 2007,31(9):1310⁃1322. doi: 10.1097/PAS.0b013e3180339f18.
|
[17] |
Smith MC, Cohen DN, Greig B, et al. The ambiguous boundary between EBV⁃related hemophagocytic lymphohistiocytosis and systemic EBV⁃driven T cell lymphoproliferative disorder[J]. Int J Clin Exp Pathol, 2014,7(9):5738⁃5749.
|
[18] |
Ferreri AJ, Govi S, Ponzoni M. Marginal zone lymphomas and infectious agents[J]. Semin Cancer Biol, 2013,23(6):431⁃440. doi: 10.1016/j.semcancer.2013.09.004.
|
[19] |
Schreuder MI, Hoefnagel JJ, Jansen PM, et al. FISH analysis of MALT lymphoma⁃specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma[J]. J Pathol, 2005,205(3):302⁃310. doi: 10.1002/path.1711.
|
[20] |
Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets[J]. Am J Surg Pathol, 2010,34(12):1830⁃1841. doi: 10.1097/PAS. 0b013e3181f72835.
|
[21] |
van Maldegem F, van Dijk R, Wormhoudt TA, et al. The majority of cutaneous marginal zone B⁃cell lymphomas expresses class⁃switched immunoglobulins and develops in a T⁃helper type 2 inflammatory environment[J]. Blood, 2008,112(8):3355⁃3361. doi: 10.1182/blood⁃2008⁃01⁃132415.
|
[22] |
Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer⁃⁃a study of 26 cases associated with various sources of immunosuppression[J]. Am J Surg Pathol, 2010,34(3):405⁃417. doi: 10.1097/PAS.0b013e3181cf8622.
|